Joel S. Schuman, MD, FACS is the Kenneth L. Roper Endowed Chair and Vice Chair for Research Innovation, Vicki and Jack Vickie and Jack Farber Vision Research Center, Wills Eye Hospital, Co-Director of the Glaucoma Service at Wills Eye Hospital and Professor of Ophthalmology, Wills Eye Hospital and Sidney Kimmel Medical College at Thomas Jefferson University. In addition, he is Professor of Biomedical Engineering at Drexel University School of Biomedical Engineering, Science and Health Systems. Prior to this he was the Elaine Langone Professor of Ophthalmology and Professor of Neuroscience & Physiology at NYU Langone Health, NYU Grossman School of Medicine; Professor of Biomedical Engineering and Electrical & Computer Engineering at NYU Tandon School of Engineering and Professor of Neural Science in the Center for Neural Science at NYU College of Arts and Sciences. He chaired the ophthalmology department at NYU Langone Health, NYU Grossman School of Medicine 2016-2020, and was Vice Chair for Ophthalmology Research in the department 2020-2022. Prior to arriving at NYU in 2016, he was Distinguished Professor and Chairman of Ophthalmology, Eye and Ear Foundation Endowed Chair in Ophthalmology, Director of UPMC Eye Center (2003-2016) and before that was at Tufts University 1991-2003, where he was Residency Director (1991-1999) and Glaucoma and Cataract Service Chief (1991-2003). In 1998 he became Professor of Ophthalmology, and Vice Chair in 2001.

Dr. Schuman and his colleagues were first to identify a molecular marker for human glaucoma, published in Nature Medicine in 2001. Continuously funded by the National Eye Institute as a principal investigator since 1995, he is an inventor of optical coherence tomography (OCT), used world-wide for ocular diagnostics. Dr. Schuman has published more than 450 peer-reviewed scientific journal articles.